Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin C Runnstrom

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
American Journal of Respiratory and Critical Care Medicine|May 25, 2022
Reply to Liao <i>et al.</i>: SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World AnalysisMartin C Runnstrom, F Eun-Hyung Lee
The Journal of Allergy and Clinical Immunology|November 9, 2024
ReplyPedro A Lamothe, Martin C Runnstrom, F Eun-Hyung Lee
American Journal of Respiratory and Critical Care Medicine|October 14, 2020
Wiping Out Wheezing: Novel Therapeutic Targets for Patients with Severe AsthmaRichard P Ramonell, Martin C Runnstrom, Philip Yang, et al.
American Journal of Respiratory and Critical Care Medicine|February 18, 2022
Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for AsthmaMartin C Runnstrom, Andrea Morrison-Porter, Mayuran Ravindran, et al.
The Journal of Allergy and Clinical Immunology. Global|December 31, 2024
Anti-IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosisPedro A Lamothe, Charles Lewis Humphrey Pruett, Natalia Smirnova, et al.
Nature Medicine|September 27, 2024
SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccinationDoan C Nguyen, Ian T Hentenaar, Andrea Morrison-Porter, et al.
Journal of Clinical Microbiology|February 2, 2022
Detection of Newly Secreted Antibodies Predicts Nonrecurrence in Primary Clostridioides difficile InfectionNatalie S Haddad, Sophia Nozick, Geena Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatmentCaterina E Faliti, Fabliha A Anam, Narayanaiah Cheedarla, et al.
Nature|August 31, 2022
Dysregulated naive B cells and de novo autoreactivity in severe COVID-19Matthew C Woodruff, Richard P Ramonell, Natalie S Haddad, et al.
Nature Immunology|December 2, 2024
Publisher Correction: Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLECaterina E Faliti, Trinh T P Van, Fabliha A Anam, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
American Journal of Respiratory and Critical Care Medicine|May 25, 2022
Reply to Liao <i>et al.</i>: SARS-CoV-2 mRNA Vaccine Antibody Response in Patients with Asthma Receiving Biologic Therapy: A Real-World AnalysisMartin C Runnstrom, F Eun-Hyung Lee
The Journal of Allergy and Clinical Immunology|November 9, 2024
ReplyPedro A Lamothe, Martin C Runnstrom, F Eun-Hyung Lee
American Journal of Respiratory and Critical Care Medicine|October 14, 2020
Wiping Out Wheezing: Novel Therapeutic Targets for Patients with Severe AsthmaRichard P Ramonell, Martin C Runnstrom, Philip Yang, et al.
American Journal of Respiratory and Critical Care Medicine|February 18, 2022
Reduced COVID-19 Vaccine Response in Patients Treated with Biologic Therapies for AsthmaMartin C Runnstrom, Andrea Morrison-Porter, Mayuran Ravindran, et al.
The Journal of Allergy and Clinical Immunology. Global|December 31, 2024
Anti-IL-4Ra therapy is superior to other biologic classes in treating allergic bronchopulmonary aspergillosisPedro A Lamothe, Charles Lewis Humphrey Pruett, Natalia Smirnova, et al.
Nature Medicine|September 27, 2024
SARS-CoV-2-specific plasma cells are not durably established in the bone marrow long-lived compartment after mRNA vaccinationDoan C Nguyen, Ian T Hentenaar, Andrea Morrison-Porter, et al.
Journal of Clinical Microbiology|February 2, 2022
Detection of Newly Secreted Antibodies Predicts Nonrecurrence in Primary Clostridioides difficile InfectionNatalie S Haddad, Sophia Nozick, Geena Kim, et al.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Poor immunogenicity upon SARS-CoV-2 mRNA vaccinations in autoimmune SLE patients is associated with pronounced EF-mediated responses and anti-BAFF/Belimumab treatmentCaterina E Faliti, Fabliha A Anam, Narayanaiah Cheedarla, et al.
Nature|August 31, 2022
Dysregulated naive B cells and de novo autoreactivity in severe COVID-19Matthew C Woodruff, Richard P Ramonell, Natalie S Haddad, et al.
Nature Immunology|December 2, 2024
Publisher Correction: Disease-associated B cells and immune endotypes shape adaptive immune responses to SARS-CoV-2 mRNA vaccination in human SLECaterina E Faliti, Trinh T P Van, Fabliha A Anam, et al.
Pageof 2